The stock market cxo generally refers to the pharmaceutical R & D and production outsourcing enterprises, which includes CRO/CMO/CDMO, that is, contract research and development services organization, contract manufacturing business organization cxo pharmaceutical leading stocks are Medici, Zhaoyan New Drugs, Kanglong Huacheng, WuXi Kangde, and Taige Pharmaceutical.
1. WuXi AppTec (603259):Clinical side CRO/CDMO enterprise leader. WuXi AppTec (stock code: 603259.SH/2359.HK) provides a full range of integrated new drug development and manufacturing services for the global biopharmaceutical industry. By empowering global pharmaceutical, biotechnology and medical device companies, WuXi AppTec is committed to advancing the process of new drug discovery and development to bring breakthrough therapeutic solutions to patients. Based on the principle of "Research First, Customer Focus", WuXi AppTec helps its customers improve their R&D efficiency through cost-effective and efficient R&D services covering chemical R&D and manufacturing, cellular and gene therapy R&D and manufacturing, medical device testing, and other areas.
2. Kanglong Huacheng (300759): the clinical side of the CRO enterprise dragon two. Kanglong Huacheng (Beijing) New Drug Technology Co. The company is a wholly owned U.S. enterprise established in 2003, providing comprehensive drug preclinical research and development services for global pharmaceutical companies and biopharmaceutical R&D organizations.
3. Zhaoyan New Drug (603127): clinical side CRO enterprises, segmentation leader. Beijing Zhaoyan New Drug Research Center Co., Ltd. was registered in the Development Zone Branch on 1998-02-25. Legal representative Feng Yuxia.
On November 26, 2019, it was selected to be on the list of 2019 National Small and Medium-sized Enterprises Public **** Service Demonstration Platforms.
4. Medicine Stone Technology (300725): clinical-side CRO company, segmented into Tiger Pharmaceuticals revenue compound growth of 27.24%. Nanjing Medicine Stone Technology Co., Ltd. was registered on December 26, 2006 in Nanjing Municipal Administration for Industry and Commerce, Nanjing High-tech Industrial Development Zone Branch. Legal representative Yang Minmin, the company's scope of business includes technology development, technology consulting, technology services in the field of biomedical expertise.